A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance

More than one year into a global pandemic, SARS-CoV-2 is now defined by a variety of rapidly evolving variant lineages. Several FDA authorized molecular diagnostic tests have been impacted by viral variation, while no reports of viral variation affecting antigen test performance have occurred to dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourassa, Lori, Perchetti, Garrett A., Phung, Quynh, Lin, Michelle J., Mills, Margaret G., Roychoudhury, Pavitra, Harmon, Kimberly G., Reed, Jonathan C., Greninger, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219478/
https://www.ncbi.nlm.nih.gov/pubmed/34171548
http://dx.doi.org/10.1016/j.jcv.2021.104900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219478/
https://www.ncbi.nlm.nih.gov/pubmed/34171548
http://dx.doi.org/10.1016/j.jcv.2021.104900

Ejemplares similares